Image

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)

Hope Study: Exploring sensory stimulation for Alzheimer's disease.

Recruiting
50-90 years
All
Phase N/A

Study Summary: This study is testing new sensory treatments for people with mild to moderate Alzheimer's disease, a brain condition that affects memory and thinking. Participants will be randomly placed in one of two groups for daily treatment over 12 months. One group will use an Active Sensory Stimulation System, while the other will use a Sham (fake) system. The study aims to see if the Active System helps slow down Alzheimer's progression.

Key Points:

  • The study lasts for about 13 months, requiring several visits, including a safety check at the end.
  • Participants will have treatments daily and may need to give spinal fluid samples at certain times.
  • Only people aged 50-90, with certain health conditions, can participate.

The study checks how well participants can do daily activities and tests their memory. Participants need to have a study partner and meet specific health and lifestyle criteria. They should not have other serious brain-related illnesses, recent hospital visits, or certain medical treatments. More details are available on the study's website: Hope Study for Alzheimer's.

Study details
    Alzheimer Disease
    Alzheimer Disease 1
    Alzheimer Disease 2
    Alzheimer Disease 3
    Alzheimer Disease
    Early Onset
    Alzheimer Disease
    Late Onset
    Alzheimer Disease 9
    Alzheimer Disease 4
    Alzheimer Disease 7
    Alzheimer Disease 17
    Alzheimer's Dementia Late Onset
    Alzheimer Disease 5
    Alzheimer Disease 6
    Alzheimer Disease 8
    Alzheimer Disease 10
    Alzheimer Disease 11
    Alzheimer Disease 12
    Alzheimer Disease 13
    Alzheimer Disease 14
    Alzheimer Disease 15
    Alzheimer Disease 16
    Alzheimer Disease 18
    Alzheimer Disease 19
    Dementia
    Dementia Alzheimers
    Dementia
    Mild
    Dementia of Alzheimer Type
    Dementia Moderate
    Dementia Senile
    Mild Cognitive Impairment
    Mild Dementia
    MCI
    Cognitive Impairment
    Cognitive Decline
    Cognitive Impairment
    Mild

NCT05637801

Cognito Therapeutics, Inc.

12 January 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.